Adrian Taylor Shields, LCSW | |
76 Capital Way Ste C, Atoka, TN 38004-6866 | |
(901) 840-1202 | |
(901) 840-1204 |
Full Name | Adrian Taylor Shields |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 76 Capital Way Ste C, Atoka, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235776477 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 6687 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Adrian Taylor Shields, LCSW P O Box 1000 Dept 978, Memphis, TN 38148-0001 Ph: (901) 840-1202 | Adrian Taylor Shields, LCSW 76 Capital Way Ste C, Atoka, TN 38004-6866 Ph: (901) 840-1202 |
News Archive
On Tuesday, the Supreme Court will hear arguments in Mutual Pharmaceutical v. Bartlett, a case about the ability of consumers to bring lawsuits against the makers of generic drugs.
Like a dairy farmer tending to a herd of cows to produce milk, researchers are tending to colonies of the bacteria Escherichia coli (E. coli) to produce new forms of antibiotics - including three that show promise in fighting drug-resistant bacteria.
Merck, a leading science and technology company, today released the Supporting Women With Cancer report, presenting findings from a global survey of 4,585 women across 23 countries.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
The Washington Post examines how the "discovery of an almost untreatable form of tuberculosis [TB] in India has set off alarm bells around the world and helped spur a dramatic expansion of government efforts to battle the killer lung disease."
› Verified 8 days ago